Business Description
Theraclion
ISIN : FR0010120402
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.01 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | -0.95 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.41 | |||||
Beneish M-Score | -0.82 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.2 | |||||
3-Year EBITDA Growth Rate | 44.3 | |||||
3-Year EPS without NRI Growth Rate | 29.1 | |||||
3-Year FCF Growth Rate | 36.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -99.99 | |||||
12-1 Month Momentum % | -99.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 2.87 | |||||
Cash Ratio | 1.72 | |||||
Days Inventory | 382.06 | |||||
Days Sales Outstanding | 643.61 | |||||
Days Payable | 244.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -41.4 | |||||
Shareholder Yield % | -65.38 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 2.1 | |||||
Operating Margin % | -244.66 | |||||
Net Margin % | -286.44 | |||||
FCF Margin % | -202.58 | |||||
ROE % | -86.5 | |||||
ROA % | -20.62 | |||||
ROIC % | -27.58 | |||||
3-Year ROIIC % | 64.06 | |||||
ROC (Joel Greenblatt) % | -196.25 | |||||
ROCE % | -35.85 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 11.39 | |||||
PB Ratio | 2.57 | |||||
EV-to-EBIT | -1.86 | |||||
EV-to-EBITDA | -4.24 | |||||
EV-to-Revenue | 6.79 | |||||
EV-to-FCF | -3.35 | |||||
Earnings Yield (Greenblatt) % | -53.76 | |||||
FCF Yield % | -17.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TCLIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Theraclion Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1.393 | ||
EPS (TTM) ($) | -0.09 | ||
Beta | -0.1 | ||
Volatility % | 99.99 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.007805 | ||
20-Day SMA ($) | 0.00017 | ||
12-1 Month Momentum % | -99.99 | ||
52-Week Range ($) | 0.00017 - 2.28 | ||
Shares Outstanding (Mil) | 45.68 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Theraclion Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Theraclion Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Theraclion Frequently Asked Questions
What is Theraclion(TCLIF)'s stock price today?
When is next earnings date of Theraclion(TCLIF)?
Does Theraclion(TCLIF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |